BNTC Return on Tangible Equity | Benitec Biopharma Inc.

Benitec Biopharma Inc. (BNTC) Return on Tangible Equity

2026-03-31: Return Tang Equity -22.66%.
2025-12-31: Return Tang Equity -23.54%.
2025-09-30: Return Tang Equity -44.68%.
2025-06-30: Return Tang Equity -38.97%.

Complete source-backed return tang equity history.

Available history: 2019-06-30 to 2026-03-31
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-03-31	-22.66%
2025-12-31	-23.54%
2025-09-30	-44.68%
2025-06-30	-38.97%
2025-03-31	-34.67%
2024-12-31	-31.09%
2024-09-30	-32.50%
2024-06-30	-46.04%
2024-03-31	-188.63%
2023-12-31	-140.98%
2023-09-30	-91.55%
2023-06-30	-9684.16%
2023-03-31	-423.68%
2022-12-31	-209.54%
2022-09-30	-124.93%
2022-06-30	-631.78%
2022-03-31	-227.98%
2021-12-31	-164.06%
2021-09-30	-104.74%
2021-06-30	-69.38%
2021-03-31	-117.24%
2020-12-31	-75.26%
2020-09-30	-127.26%
2020-06-30	-80.82%

Annual Return Tang Equity

Date	Return Tang Equity
2025-06-30	-38.97%
2024-06-30	-46.04%
2023-06-30	-9684.16%
2022-06-30	-631.78%
2021-06-30	-69.38%
2020-06-30	-80.82%
2019-06-30	15.72%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BioAge Labs, Inc. (BIOA)	United States	$0.333B	-11.88
Larimar Therapeutics, Inc. (LRMR)	United States	$0.344B	-1.83
Emergent BioSolutions Inc. (EBS)	United States	$0.347B	-2.43
ENANTA PHARMACEUTICALS INC (ENTA)	United States	$0.349B	-6.72
BridgeBio Oncology Therapeutics, Inc. (BBOT)	United States	$0.320B	-3.35
Evommune, Inc. (EVMN)	United States	$0.320B	-5.10
Vogenx, Inc. (VOGX)	United States	$0.355B
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58